Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Drug record: Amiloride
Product Insert, Amiloride HCl Tablets
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
Substance Name: Naltrexone
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
The natural course of clinically isolated syndrome in pediatric patients.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.

Pages